World Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

World Investment Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$254K	Sell	1,924 -27	-1%	-$3.65K	﹤0.01%	1318
2026 Q1	$249K	Sell	1,951 -34	-2%	-$4.24K	﹤0.01%	1363
2025 Q4	$242K	Buy	+1,985	New	+$228K	﹤0.01%	1290
2025 Q2	–	Sell	-8,264	Closed	-$670K	–	1204
2025 Q1	$670K	Sell	8,264 -193	-2%	-$17.3K	0.02%	606
2024 Q4	$762K	Buy	+8,457	New	+$819K	0.02%	545

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

World Investment Advisors's XBI Position: Q2 2026 in Review

World Investment Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 1.4% in Q2 2026, selling an estimated $3.65K and leaving 1,924 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #1318.

World Investment Advisors first reported a position in XBI in Q4 2024 and has held it in 5 quarters since. The position peaked at $762K in Q4 2024. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

World Investment Advisors held 1,924 shares of State Street SPDR S&P Biotech ETF worth $254K as of Q2 2026.
World Investment Advisors sold 27 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $3.65K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of World Investment Advisors's portfolio in Q2 2026, its #1318 holding.
World Investment Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 5 quarters since.
World Investment Advisors's State Street SPDR S&P Biotech ETF position peaked at $762K in Q4 2024.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.